This is to further inform that there has been no change in the rating assigned to the Company's facility previously assigned by Acuité Ratings & Research. The details of the change in outlook is as below:

Dropline overdraft (long term rating) - ACUITE BB+ (Under rating watch with developing implications)

Proposed Commercial Paper (short term rating) - ACUITE A4+ (Under rating watch with developing implications)